Labiana Health, S.A. (BME:LAB)
Spain · Delayed Price · Currency is EUR 6.25
-0.05 (-0.79%)
Last updated: Aug 27, 2026, 12:57 PM CET
Labiana Health Revenue
In the year 2025, Labiana Health had annual revenue of 75.18M EUR with 13.47% growth. Labiana Health had revenue of 35.98M in the half year ending December 31, 2025, with 19.93% growth.
Revenue
75.18M
Revenue Growth
+13.47%
P/S Ratio
0.68
Revenue / Employee
204.94K
Employees
373
Market Cap
52.28M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 75.18M | 8.92M | 13.47% |
| Dec 31, 2024 | 66.26M | 7.79M | 13.33% |
| Dec 31, 2023 | 58.46M | 613.91K | 1.06% |
| Dec 31, 2022 | 57.85M | 892.44K | 1.57% |
| Dec 31, 2021 | 56.96M | -883.02K | -1.53% |
| Dec 31, 2020 | 57.84M | 9.62M | 19.96% |
| Dec 31, 2019 | 48.21M | 5.44M | 12.72% |
| Dec 31, 2018 | 42.78M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.42B |
| Almirall | 1.16B |
| Laboratorios Farmaceuticos Rovi | 773.05M |
| Laboratorio Reig Jofre | 337.73M |
| Prim, S.A. | 250.65M |
| Pharma Mar | 218.64M |
| Atrys Health | 144.31M |
| Pangaea Oncology | 16.73M |